Clinical Trial

The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck

Study acronym: FORCE
Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
en-label, proof-of-concept study designed to evaluate the feasibility, safety, and acceptability of a prophylactic fish oil-enriched nutritional supplement (Fresubin Supportan) in patients with head and neck cancer (HNC) undergoing curative-intent chemoradiotherapy (CRT) at the University of Kansas Medical Center. The study involves daily supplementation starting two weeks prior to CRT and continuing throughout CRT, alongside weekly nutrition counseling.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-12-31 -> 2028-05-31 2026-08-08
minor Completion pushed: 2027-12-31 -> 2028-12-31 2026-08-08
Trial Details
NCT Number NCT07180576
Lead Sponsor Anna Arthur, PhD
Collaborators: Fresenius Kabi
Conditions Head & Neck Squamous Cell Carcinoma
Enrollment 15 participants
Start Date 2027-06-01
Primary Completion 2028-05-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-07